Insider trades
Alexandra Balcom, Director of Crescent Biopharma CBIO, has filed 0 purchases and 80 sales on the open market. Over the past 12 months that comes to a net sale of $16.5M. The latest trade was on 06/02.
Alexandra Balcom
Director
- Company
- Crescent Biopharma CBIO
- First filing
- 23/01/06
- Trades
- 149 trades
- Buys / sales
- 0 / 80
- 12-month net buying
- −$16.5M
- Last trade
- 06/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/01 | 06/03 | 11,430 sh8 trades | $98.69avg. | $1,128,080.49 | −11.8% | |
| Open-market sale10b5-1 plan | 05/01 | 05/05 | 11,430 sh3 trades | $99.00avg. | $1,131,600.38 | −11.8% | |
| Open-market sale10b5-1 plan | 04/01 | 04/03 | 11,430 sh3 trades | $105.21avg. | $1,202,526.68 | −11.8% | |
| Open-market sale10b5-1 plan | 03/24–03/25 | 03/26 | 25,130 sh4 trades | $98.15avg. | $2,466,610.45 | −22.7% | |
| Open-market sale10b5-1 plan | 01/05–01/06 | 01/07 | 7,417 sh7 trades | $97.25avg. | $721,320.39 | −8.3% | |
| Open-market sale10b5-1 plan | 25/12/08 | 25/12/10 | 7,084 sh2 trades | $110.32avg. | $781,537.04 | −11.5% | |
| Open-market sale10b5-1 plan | 25/11/17–25/11/18 | 25/11/19 | 20,729 sh8 trades | $99.62avg. | $2,065,030.33 | −25.1% | |
| Open-market sale10b5-1 plan | 25/10/15 | 25/10/17 | 1,683 sh | $85.57 | $144,014.31 | −2.7% | |
| Open-market sale10b5-1 plan | 25/10/13–25/10/14 | 25/10/15 | 40,000 sh7 trades | $87.36avg. | $3,494,303.1 | −39.3% | |
| Open-market sale10b5-1 plan | 25/10/01 | 25/10/03 | 20,000 sh2 trades | $85.48avg. | $1,709,511.8 | −24.5% | |
| Open-market sale10b5-1 plan | 25/09/29–25/09/30 | 25/10/01 | 27,588 sh2 trades | $85.05avg. | $2,346,255.88 | −30.9% | |
| Open-market sale10b5-1 plan | 25/07/15–25/07/16 | 25/07/17 | 20,000 sh5 trades | $84.67avg. | $1,693,496.1 | −24.5% | |
| Open-market sale10b5-1 plan | 25/06/27 | 25/07/01 | 20,000 sh | $80.02 | $1,600,400 | −24.5% | |
| Open-market sale10b5-1 plan | 25/01/06 | 25/01/08 | 4,016 sh3 trades | $79.68avg. | $320,009.01 | −6.1% | |
| Open-market sale10b5-1 plan | 24/11/29 | 24/12/03 | 10,000 sh2 trades | $95.79avg. | $957,940.48 | −23.1% | |
| Open-market sale10b5-1 plan | 24/10/31 | 24/11/04 | 10,000 sh4 trades | $89.19avg. | $891,879.4 | −23.1% | |
| Open-market sale10b5-1 plan | 24/09/30 | 24/10/02 | 10,000 sh4 trades | $101.06avg. | $1,010,619.68 | −23.1% | |
| Open-market sale10b5-1 plan | 24/08/30 | 24/09/04 | 10,000 sh3 trades | $84.23avg. | $842,349 | −23.1% | |
| Open-market sale10b5-1 plan | 24/07/31 | 24/08/02 | 10,000 sh5 trades | $79.51avg. | $795,074.36 | −23.1% | |
| Open-market sale10b5-1 plan | 24/06/28 | 24/07/02 | 10,000 sh3 trades | $75.43avg. | $754,341.28 | −23.1% |